当前位置:首页 - 行情中心 - 三诺生物(300298) - 财务分析

三诺生物

(300298)

  

流通市值:94.55亿  总市值:117.38亿
流通股本:4.51亿   总股本:5.60亿

三诺生物(300298)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.82亿元,每股收益0.33元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益376647.51万元,未分配利润120590.54万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产602533.63万元,负债225886.12万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入2,263,667,609.811,041,603,772.084,443,123,570.613,182,048,562.89
营业总成本2,116,582,036988,932,886.514,041,229,082.162,922,130,369.96
其他经营收益
营业利润192,413,943.3793,087,025.77398,977,729.7321,159,830.3
利润总额206,875,786.593,047,997.03395,261,182.41318,593,473.26
净利润182,071,127.8481,361,076.86345,854,598.97271,627,606.54
每股收益
其他综合收益13,304,077.19-7,243,403.2724,447,503.61-56,311,165.52
综合收益总额195,375,205.0374,117,673.59370,302,102.58215,316,441.02
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,357,921,451.122,325,701,337.462,381,879,275.582,211,056,219.37
非流动资产:
非流动资产合计3,667,414,832.733,667,951,241.423,715,685,676.83,722,382,845.5
资产总计6,025,336,283.855,993,652,578.886,097,564,952.385,933,439,064.87
流动负债:
流动负债合计1,548,464,272.331,436,504,702.251,693,710,727.361,561,089,601.73
非流动负债:
非流动负债合计710,396,955.25707,087,470.57634,238,042.5797,146,780.7
负债合计2,258,861,227.582,143,592,172.822,327,948,769.862,358,236,382.43
所有者权益(或股东权益):
归属于母公司股东权益合计3,344,792,032.273,430,657,013.793,357,739,858.83,176,804,525.74
股东权益合计3,766,475,056.273,850,060,406.063,769,616,182.523,575,202,682.44
负债和股东权益合计6,025,336,283.855,993,652,578.886,097,564,952.385,933,439,064.87
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计2,378,494,643.811,221,076,384.984,493,985,390.693,260,494,688.08
经营活动现金流出小计2,105,129,812.181,023,997,765.13,862,696,491.522,857,328,482.76
经营活动产生的现金流量净额273,364,831.63197,078,619.88631,288,899.17403,166,205.32
投资活动产生的现金流量:
投资活动现金流入小计570,807,235.26314,164,040.59491,652,546.59267,376,398.35
投资活动现金流出小计621,481,224.74269,346,029.2666,668,722.05366,036,824.52
投资活动产生的现金流量净额-50,673,989.4844,818,011.39-175,016,175.46-98,660,426.17
筹资活动产生的现金流量:
筹资活动现金流入小计149,435,572.6595,764,138.73231,514,750.0294,488,083.34
筹资活动现金流出小计463,916,611.43250,286,363.4615,788,268.02373,774,627.75
筹资活动产生的现金流量净额-314,481,038.78-154,522,224.67-384,273,518-279,286,544.41
汇率变动对现金及现金等价物的影响1,870,204.87577,999.3-9,210,729.26-13,889,201.94
现金及现金等价物净增加额-89,919,991.7687,952,405.962,788,476.4511,330,032.8
期末现金及现金等价物余额752,534,900.46929,415,113.25842,454,892.22790,996,448.57
补充资料:
现金及现金等价物的净增加额-89,919,991.76-62,788,476.45-
最新报告期:2025-08-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华源证券刘闯0.720.881.052025-08-29
湘财证券蒋栋0.720.901.062025-08-28
国金证券何冠洲0.760.921.152025-08-27
华泰证券代雯,高鹏,杨昌源0.710.871.022025-08-27
TOP↑